OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STUDY OF LONG-TERM CLINICAL AND PATHOGENETIC EFFECTS OF FAVIPIRAVIR-BASED ANTI-VIRAL DRUG IN PATIENTS WITH METABOLIC SYNDROME IN POST-COVID PERIOD
О. А. Радаева, Л. А. Балыкова, K. Ya. Zaslavskaya, et al.
Pharmacy & Pharmacology (2022) Vol. 10, Iss. 2, pp. 217-228
Open Access | Times Cited: 5

Showing 5 citing articles:

Phase I Pharmacokinetics Study of Drug Areplivir® Zinc (INN: Favipiravir + Zinc Gluconate) (LLC "PROMOMED RUS", Russia)
Т. Н. Комаров, N. S. Bagaevа, K. K. Karnakova, et al.
Drug development & registration (2024) Vol. 13, Iss. 1, pp. 281-290
Open Access

In Vitro Study of the Cytotoxic and Immunotropic Effects of Molnupiravir and Favipiravir
E. P. Brodovskaya, K. Ya. Zaslavskaya, Anjum Ayub, et al.
Pharmaceutical Chemistry Journal (2024) Vol. 57, Iss. 11, pp. 1693-1697
Closed Access

Clinical observation of the long-term course of COVID-19 infection in a patient with an immunodeficiency condition
N. S. Nikolaeva, О. О. Воронкова, S. Glukhova, et al.
Meditsinskiy sovet = Medical Council (2024), Iss. 9, pp. 133-142
Open Access

ETIOTROPIC THERAPY OF MILD COVID-19 IN OUTPATIENT PATIENTS: MOLNUPIRAVIR IS IN FOCUS
Л. А. Балыкова, N. Pshenichnaya, Х.Г. Омарова, et al.
Acta medica Eurasica (2023), Iss. 3, pp. 1-15
Closed Access



Acta medica Eurasica (2023), Iss. 3
Open Access

Page 1

Scroll to top